Literature DB >> 22960548

Involvement of arginine-vasopressin in the diuretic and hypotensive effects of Pereskia grandifolia Haw. (Cactaceae).

Caroline Calixto Kazama1, Denise Thiemi Uchida, Karina Natally Canzi, Priscila de Souza, Sandra Crestani, Arquimedes Gasparotto, Antonio Laverde.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Pereskia grandifolia Haw. (Cactaceae), popularly known as "ora-pro-nobis" is well recognized in Brazilian traditional medicine as a diuretic agent, although no scientific data have been published to support this effect. The aim of this work is to evaluate the diuretic and hypotensive activities of the infusion (INFPG) and the ethanol extract (HEPG) of Pereskia grandifolia and possible mechanism of action.
MATERIALS AND METHODS: The infusions (2.5-10%) and the HEPG (3-100 mg/kg) were orally administered in a single dose or daily (for seven days) to rats. The urine excretion rate, pH, density, conductivity and content of Na(+), K(+), Cl(-) and HCO(3)(-) were measured in the urine of saline-loaded animals. In collected serum samples the concentration of electrolytes, urea, creatinine, aldosterone, vasopressin and angiotensin converting enzyme (ACE) activity were evaluated. The involvement of V(2) vasopressin receptor in the diuretic activity and the hypotensive effect of HEPG were also determined.
RESULTS: Water excretion rate was significantly increased by HEPG, while the urinary K(+) and Cl(-) excretion was significantly reduced in acute and prolonged treatment. The oral administration of the HEPG (30mg/kg) significantly reduced serum levels of vasopressin and the mean arterial pressure (MAP) in normotensive rats. All other evaluated parameters have not been affected by any treatment.
CONCLUSION: The results showed that HEPG could present compound(s) responsible for aquaretic activities with no signs of toxicity, and this effect could involve a reduction in the arginine-vasopressin release.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22960548     DOI: 10.1016/j.jep.2012.08.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Diuretic effect of extracts, fractions and two compounds 2α,3β,19α-trihydroxy-urs-12-en-28-oic acid and 5-hydroxy-3,6,7,8,4'-pentamethoxyflavone from Rubus rosaefolius Sm. (Rosaceae) leaves in rats.

Authors:  Priscila de Souza; Thaise Boeing; Lincon Bordignon Somensi; Camile Cecconi Cechinel-Zanchett; Jairo Kenupp Bastos; Marcel Petreanu; Rivaldo Niero; Valdir Cechinel-Filho; Luisa Mota da Silva; Sérgio Faloni de Andrade
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-24       Impact factor: 3.000

Review 2.  The biological activities and chemical composition of Pereskia species (Cactaceae)--a review.

Authors:  Nícolas de Castro Campos Pinto; Elita Scio
Journal:  Plant Foods Hum Nutr       Date:  2014-09       Impact factor: 3.921

3.  Effects of Pereskia aculeate Miller Petroleum Ether Extract on Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Rats and its Potential Molecular Mechanisms.

Authors:  Yifei Chen; Kaifei Liu; Yingyuan Qin; Suyi Chen; Guokai Guan; Yao Huang; Yu Chen; Zhixian Mo
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

Review 4.  A Review of Botanical Characteristics, Traditional Usage, Chemical Components, Pharmacological Activities, and Safety of Pereskia bleo (Kunth) DC.

Authors:  Sogand Zareisedehizadeh; Chay-Hoon Tan; Hwee-Ling Koh
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-03       Impact factor: 2.629

5.  Influence of Harvest Time on the Chemical Profile of Pereskia aculeate Mill. Using Paper Spray Mass Spectrometry.

Authors:  Antonio Henrique de Souza; Henrique de Oliveira Prata Mendonça; Ana Cardoso Clemente Filha Ferreira de Paula; Rodinei Augusti; Camila Argenta Fante; Júlio Onésio Ferreira Melo; Lanamar de Almeida Carlos
Journal:  Molecules       Date:  2022-07-02       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.